Literature DB >> 8097210

Effect of hypothermia and sampling site on blood esmolol concentrations.

J R Jacobs1, N D Croughwell, D K Goodman, W D White, J G Reves.   

Abstract

Esmolol hydrochloride was administered by constant-rate continuous infusion to 10 patients undergoing hypothermic cardiopulmonary bypass for coronary artery revascularization surgery. After a suitable loading dose, the esmolol infusion was started approximately 30 minutes before bypass and was stopped 10 minutes after termination of bypass. Esmolol concentrations were measured in arterial and venous blood samples collected before and after bypass and in samples taken from the inflow and outflow ports of the membrane oxygenator during bypass. Blood esmolol concentrations increased during hypothermia in a manner that correlated significantly and inversely with temperature. All patients were separated from the extracorporeal circulation without difficulty, and the average arterial esmolol concentration was slightly below the prebypass concentration within minutes of discontinuing bypass. Esmolol disappeared from the blood rapidly on terminating the infusion. There was no difference between esmolol concentrations measured simultaneously from the inflow and outflow ports of the membrane oxygenator during bypass, but radial arterial esmolol concentrations before and after bypass were on average about sevenfold higher than forearm venous esmolol concentrations during the esmolol infusion. The results of this study lead to two important conclusions: (1) in vivo clearance of esmolol demonstrates acute temperature dependence and (2) esmolol is removed irreversibly as it passes through the microcirculation of the hand, making measurement of peripheral esmolol concentrations markedly dependent on sampling site (arterial versus venous).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097210     DOI: 10.1002/j.1552-4604.1993.tb04670.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  5 in total

1.  Pharmacokinetics of eltanolone following bolus injection and constant rate infusion.

Authors:  K Parivar; A Wessén; M Widman; A Nilsson
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

2.  The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.

Authors:  Peter C Adamson; Larry A Rhodes; J Philip Saul; MacDonald Dick; Michael R Epstein; Peter Moate; Raymond Boston; Mark S Schreiner
Journal:  Pediatr Cardiol       Date:  2006-07-11       Impact factor: 1.655

Review 3.  Clinical pharmacokinetics and therapeutic efficacy of esmolol.

Authors:  Donald B Wiest; Jason S Haney
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 4.  Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.

Authors:  D Wiest
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

5.  Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol.

Authors:  Günther Krumpl; Ivan Ulč; Michaela Trebs; Juri Hodisch; Pavla Kadlecová; Bernhard Husch
Journal:  Cureus       Date:  2020-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.